Similarweb Ltd. (NYSE:SMWB – Get Free Report) has been given a consensus recommendation of “Hold” by the eleven analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $7.0714.
A number of analysts have weighed in on SMWB shares. Oppenheimer cut their price target on Similarweb from $7.00 to $4.00 and set an “outperform” rating on the stock in a research note on Thursday, February 19th. Barclays cut their price target on Similarweb from $7.00 to $5.00 and set an “overweight” rating on the stock in a research note on Monday, April 20th. Citigroup cut Similarweb from a “buy” rating to a “neutral” rating and cut their price target for the company from $8.50 to $3.00 in a research note on Friday, April 10th. Wall Street Zen cut Similarweb from a “buy” rating to a “hold” rating in a research note on Saturday, February 21st. Finally, Northland Securities cut Similarweb from an “outperform” rating to a “market perform” rating and set a $5.00 price target on the stock. in a research note on Wednesday, February 18th.
Read Our Latest Research Report on Similarweb
Insider Activity at Similarweb
Institutional Investors Weigh In On Similarweb
A number of institutional investors and hedge funds have recently bought and sold shares of SMWB. Jump Financial LLC purchased a new stake in Similarweb in the second quarter valued at $1,457,000. Federated Hermes Inc. lifted its position in Similarweb by 52.4% in the second quarter. Federated Hermes Inc. now owns 48,000 shares of the company’s stock valued at $376,000 after acquiring an additional 16,500 shares during the last quarter. Qube Research & Technologies Ltd purchased a new stake in Similarweb in the second quarter valued at $878,000. Nebula Research & Development LLC purchased a new stake in Similarweb in the second quarter valued at $146,000. Finally, California State Teachers Retirement System lifted its position in Similarweb by 29.7% in the second quarter. California State Teachers Retirement System now owns 49,654 shares of the company’s stock valued at $389,000 after acquiring an additional 11,356 shares during the last quarter. 57.59% of the stock is owned by hedge funds and other institutional investors.
Similarweb Price Performance
Similarweb stock opened at $4.12 on Tuesday. Similarweb has a 1-year low of $2.22 and a 1-year high of $10.75. The stock has a market cap of $361.00 million, a PE ratio of -11.77 and a beta of 1.11. The stock’s fifty day moving average is $2.84 and its two-hundred day moving average is $4.93.
Similarweb (NYSE:SMWB – Get Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The company reported $0.01 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.01. Similarweb had a negative return on equity of 48.57% and a negative net margin of 10.38%.The company had revenue of $73.88 million for the quarter, compared to analysts’ expectations of $73.04 million. On average, research analysts expect that Similarweb will post -0.09 earnings per share for the current fiscal year.
About Similarweb
Similarweb Ltd. (NYSE: SMWB) is a digital intelligence company that provides insights into website and mobile app performance. Its cloud-based platform aggregates and analyzes data on global web traffic, user engagement, and referral sources, enabling businesses to benchmark their digital presence against competitors. The company’s core offering includes metrics on audience behavior, traffic acquisition channels, and industry trends, which are designed to inform strategic decisions in marketing, sales, and product development.
Similarweb’s platform delivers a suite of tools for market research, competitor analysis, and performance optimization.
Featured Stories
- Five stocks we like better than Similarweb
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Similarweb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Similarweb and related companies with MarketBeat.com's FREE daily email newsletter.
